Evaluation of Safety and Efficacy of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in Korea

NCT02010788 · clinicaltrials.gov ↗

COMPLETED

Status

523

Enrollment

INDUSTRY

Sponsor class

Conditions

Urinary Incontinence
Urinary Bladder, Overactive

Interventions

BIOLOGICAL: botulinum toxin Type A

Sponsor

Allergan